InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
4.520
-0.530 (-10.50%)
Jan 22, 2025, 10:43 AM EST - Market open
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $3.25 million as of January 22, 2025. Its market cap has increased by 54.55% in one year.
Market Cap
3.25M
Enterprise Value
-942.14K
1-Year Change
54.55%
Ranking
Category
Stock Price
$4.52
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $3.25M, a decrease of -87.52%. That is a compound annual growth rate of -39.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 3.60M | 5.88% |
| Dec 31, 2024 | 3.40M | 54.55% |
| Dec 29, 2023 | 2.20M | 15.79% |
| Dec 30, 2022 | 1.90M | -89.73% |
| Dec 31, 2021 | 18.50M | -19.57% |
| Dec 31, 2020 | 23.00M | -11.54% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 341.33B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |